MapLight Therapeutics, Inc.
MPLT
$13.63
$0.644.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -62.21% | -17.98% | |||
| Total Depreciation and Amortization | -21.39% | 12.93% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 92.87% | -82.23% | |||
| Change in Net Operating Assets | -2,474.77% | -69.33% | |||
| Cash from Operations | -93.74% | -28.13% | |||
| Capital Expenditure | 77.08% | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 114.40% | -- | |||
| Cash from Investing | 114.31% | 1,875,100.00% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -98.85% | 25.00% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 91.88% | -- | |||
| Cash from Financing | 90.81% | -100.04% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 88.17% | -88.10% | |||